Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

Drug Therapy for Rheumatoid Arthritis in Adults: An Update [Internet].

Donahue KE, Jonas DE, Hansen RA, Roubey R, Jonas B, Lux LJ, Gartlehner G, Harden E, Wilkins T, Peravali V, Bangdiwala SI, Yuen A, Thieda P, Morgan LC, Crotty K, Desai R, Van Noord M.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Apr.

PMID:
22696776
[PubMed]
Books & Documents
2.

Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.

Singh JA, Cameron DR.

J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18. Review.

PMID:
22656072
[PubMed - indexed for MEDLINE]
Free Article
3.

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.

Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN.

Ann Intern Med. 2008 Jan 15;148(2):124-34. Epub 2007 Nov 19. Review.

PMID:
18025440
[PubMed - indexed for MEDLINE]
4.

Mixed treatment comparison of the treatment discontinuations of biologic disease-modifying antirheumatic drugs in adults with rheumatoid arthritis.

Desai RJ, Hansen RA, Rao JK, Wilkins TM, Harden EA, Yuen A, Jonas DE, Roubey R, Jonas B, Gartlehner G, Lux L, Donahue KE.

Ann Pharmacother. 2012 Nov;46(11):1491-505. doi: 10.1345/aph.1R203. Epub 2012 Oct 23. Review.

PMID:
23092868
[PubMed - indexed for MEDLINE]
5.

Adverse effects of biologics: a network meta-analysis and Cochrane overview.

Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK, Filippini G, Skoetz N, Francis D, Lopes LC, Guyatt GH, Schmitt J, La Mantia L, Weberschock T, Roos JF, Siebert H, Hershan S, Lunn MP, Tugwell P, Buchbinder R.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008794. doi: 10.1002/14651858.CD008794.pub2. Review.

PMID:
21328309
[PubMed - indexed for MEDLINE]
6.

Biologics for rheumatoid arthritis: an overview of Cochrane reviews.

Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007848. doi: 10.1002/14651858.CD007848.pub2. Review.

PMID:
19821440
[PubMed - indexed for MEDLINE]
7.

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis.

Guyot P, Taylor P, Christensen R, Pericleous L, Poncet C, Lebmeier M, Drost P, Bergman G.

Arthritis Res Ther. 2011;13(6):R204. doi: 10.1186/ar3537. Epub 2011 Dec 12. Review.

PMID:
22151924
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis.

Doan QV, Chiou CF, Dubois RW.

J Manag Care Pharm. 2006 Sep;12(7):555-69. Review.

PMID:
16981801
[PubMed - indexed for MEDLINE]
Free Article
9.

Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).

Ramiro S, Radner H, van der Heijde D, van Tubergen A, Buchbinder R, Aletaha D, Landewé RB.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD008886. doi: 10.1002/14651858.CD008886.pub2. Review.

PMID:
21975788
[PubMed - indexed for MEDLINE]
10.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

PMID:
16948890
[PubMed - indexed for MEDLINE]
Free Article
11.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Clark W, Jobanputra P, Barton P, Burls A.

Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. Review.

PMID:
15130461
[PubMed - indexed for MEDLINE]
Free Article
12.

Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis.

Katchamart W, Trudeau J, Phumethum V, Bombardier C.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008495. doi: 10.1002/14651858.CD008495. Review.

PMID:
20393970
[PubMed - indexed for MEDLINE]
13.

A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis.

Turkstra E, Ng SK, Scuffham PA.

Curr Med Res Opin. 2011 Oct;27(10):1885-97. doi: 10.1185/03007995.2011.608655. Epub 2011 Aug 18. Review.

PMID:
21848493
[PubMed - indexed for MEDLINE]
14.

Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.

McMahan R, Balfe LM, Greene L.

J Manag Care Pharm. 2012 Jan-Feb;18(1 Suppl B):1-16. Review.

PMID:
22376227
[PubMed - indexed for MEDLINE]
Free Article
15.

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL.

Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.

PMID:
16030080
[PubMed - indexed for MEDLINE]
Free Article
16.

Anakinra for rheumatoid arthritis.

Mertens M, Singh JA.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005121. doi: 10.1002/14651858.CD005121.pub3. Review.

PMID:
19160248
[PubMed - indexed for MEDLINE]
17.

Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisal.

Yang H, Craig D, Epstein D, Bojke L, Light K, Bruce IN, Sculpher M, Woolacott N.

Pharmacoeconomics. 2012 Apr;30(4):257-70. doi: 10.2165/11595920-000000000-00000. Review.

PMID:
22283690
[PubMed - indexed for MEDLINE]
18.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
[PubMed - indexed for MEDLINE]
19.

Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis.

Katchamart W, Trudeau J, Phumethum V, Bombardier C.

Ann Rheum Dis. 2009 Jul;68(7):1105-12. doi: 10.1136/ard.2008.099861. Epub 2008 Dec 3. Review.

PMID:
19054823
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Indirect comparison of biological treatments in refractory rheumatoid arthritis.

Gallego-Galisteo M, Villa-Rubio A, Alegre-del Rey E, Márquez-Fernández E, Ramos-Báez JJ.

J Clin Pharm Ther. 2012 Jun;37(3):301-7. doi: 10.1111/j.1365-2710.2011.01292.x. Epub 2011 Aug 10. Review.

PMID:
21831256
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk